|
| EB1-dependent long survival of glioblastoma-grafted mice with the oral tubulin-binder BAL101553 is associated with inhibition of tumor angiogenesis |
|
https://doi.org/10.18632/oncotarget.27374
Raphaël Bergès, Aurélie Tchoghandjian, Arnauld Sergé, Stéphane Honoré, Dominique Figarella-Branger, Felix Bachmann, Heidi A. Lane, and Diane Braguer
|
| 759-774 |
|
| Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma |
|
https://doi.org/10.18632/oncotarget.27437
Sonali Joshi, Shawn Campbell, Jeong Y. Lim, Shannon McWeeney, Adam Krieg, Yukie Bean, Nadja Pejovic, Paulette Mhawech-Fauceglia, and Tanja Pejovic
|
| 775-783 |
|
| Both BRCA1-wild type and -mutant triple-negative breast cancers show sensitivity to the NAE inhibitor MLN4924 which is enhanced upon MLN4924 and cisplatin combination treatment |
|
https://doi.org/10.18632/oncotarget.27485
Shrilekha Misra, Xiaoli Zhang, Nissar Ahmad Wani, Steven Sizemore, and Alo Ray
|
| 784-800 |
|
| SLC25A32 sustains cancer cell proliferation by regulating flavin adenine nucleotide (FAD) metabolism |
|
https://doi.org/10.18632/oncotarget.27486
Valeria Santoro, Ilya Kovalenko, Kim Vriens, Stefan Christen, Andreas Bernthaler, Andrea Haegebarth, Sarah-Maria Fendt, and Sven Christian
|
| 801-812 |
|
| Prolyl 4-hydroxylase alpha 1 protein expression risk-stratifies early stage colorectal cancer |
|
https://doi.org/10.18632/oncotarget.27491
Atsushi Tanaka, Yihua Zhou, Jinru Shia, Fiona Ginty, Makiko Ogawa, David S. Klimstra, Ronald C. Hendrickson, Julia Y. Wang, and Michael H. Roehrl
|
| 813-824 |
|
| Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis |
|
https://doi.org/10.18632/oncotarget.27370
Minzhi Hou, Zhiqiang Cheng, Hongwei Shen, Shanyang He, Yang Li, Yunping Pan, Chongjin Feng, Xinlin Chen, Yang Zhang, Millicent Lin, Liantang Wang, and Zunfu Ke
|
| 825-826 |
|
| Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1 |
|
https://doi.org/10.18632/oncotarget.27484
Linda Pudelko, Pegah Rouhi, Kumar Sanjiv, Helge Gad, Christina Kalderén, Andreas Höglund, Massimo Squatrito, Alberto J. Schuhmacher, Steven Edwards, Daniel Hägerstrand, Ulrika Warpman Berglund, Thomas Helleday, and Lars Bräutigam
|
| 827-827 |
